Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.

<h4>Background</h4>The leading cause of mortality for patients with the neurofibromatosis type 1 (NF1) cancer predisposition syndrome is the development of malignant peripheral nerve sheath tumor (MPNST), an aggressive soft tissue sarcoma. In the setting of NF1, this cancer type frequent...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jeffrey J Szymanski, R Taylor Sundby, Paul A Jones, Divya Srihari, Noah Earland, Peter K Harris, Wenjia Feng, Faridi Qaium, Haiyan Lei, David Roberts, Michele Landeau, Jamie Bell, Yi Huang, Leah Hoffman, Melissa Spencer, Matthew B Spraker, Li Ding, Brigitte C Widemann, Jack F Shern, Angela C Hirbe, Aadel A Chaudhuri
Format:	article
Language:	EN
Published:	Public Library of Science (PLoS) 2021
Subjects:	Medicine R
Online Access:	https://doaj.org/article/c4e51b3f384e4d0d940d39076a2a352f
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/c4e51b3f384e4d0d940d39076a2a352f

Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.

Internet

Similar Items